Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
Ontosight® Newsletter Issue 3
Partnering to unlock the true potential of cannabis in medical care
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering to unlock the potential of phytocannabinoids in designing medical therapies. ESCHBORN, Germany,…
Partnering to make 100,000s COVID-19 publications searchable
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. Gunjan Bhardwaj, CEO Innoplexus discuss the importance of access to the…
Machine learning as an indispensable tool for Biopharma
The cost of developing a new drug roughly doubles every nine years (inflation-adjusted) aka Eroom’s law. As the volume of data…
Precision medicine and the discovery of biomarkers
In medicine, a Biomarker is a biological indicator, which can mark a state of a biology and is measurable. A…
FDA supports AI for drug development
AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and…
How Artificial Intelligence is accelerating research to treat COVID-19
The World Health Organization announced a pandemic in April 2020. Artificial intelligence technologies have presented effective methods for accelerating research,…
AI as an effective tool to combat the novel coronavirus pandemic
First discovered in December 2019 in China, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had spread worldwide. By April…
